| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21dd0e090a3c11b14df0ced94f534c9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72d94b9abca7ae09fd0101e3d877a21e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22977a6c1b6318289ae4636890f8cec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3287d1522e00eaf85f1b3ccb5cf1a4b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fd9c2310ed4d26a9c5eec264b807e0a |
| publicationDate |
2010-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2259776-A1 |
| titleOfInvention |
Topotecan ready to use solutions |
| abstract |
Aqueous-based, ready to use topotecan-containing formulations for parenteral use having extended stability are disclosed. The formulations are surprisingly free of precipitated degradation products such as 10-hydroxycamptothecin (10-HCPT) after periods of up to 1 year or greater. |
| priorityDate |
2008-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |